VACCINES CONTAINING HYBRID POLYPEPTIDES CONSISTING OF AT LEAST TWO DIFFERENT ALLERGENIC PROTEINS

摘要

Hybrid polypeptides comprising at least two different allergenic proteins or fragments thereof wherein each fragment consists of at least eight consecutive amino acids of the respective allergenic protein are disclosed. The hybrid polypeptides and polynucleotides coding therefor can be used as pharmaceutical compositions, in particular as vaccines.